መነሻCGEN • NASDAQ
add
Compugen Ltd
የቀዳሚ መዝጊያ
$1.61
የቀን ክልል
$1.62 - $1.68
የዓመት ክልል
$1.35 - $2.80
የገበያው አጠቃላይ ዋጋ
150.41 ሚ USD
አማካይ መጠን
527.13 ሺ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
NASDAQ
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (USD) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | 1.47 ሚ | -95.60% |
የሥራ ወጪ | 8.28 ሚ | -38.54% |
የተጣራ ገቢ | -6.12 ሚ | -162.98% |
የተጣራ የትርፍ ክልል | -415.84 | -1,532.45% |
ገቢ በሼር | -0.07 | -163.64% |
EBITDA | -7.36 ሚ | -140.66% |
ውጤታማ የግብር ተመን | -0.07% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (USD) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 103.26 ሚ | 103.72% |
አጠቃላይ ንብረቶች | 115.00 ሚ | -5.22% |
አጠቃላይ ተጠያቂነቶች | 60.08 ሚ | 7.72% |
አጠቃላይ እሴት | 54.91 ሚ | — |
የሼሮቹ ብዛት | 93.51 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 2.64 | — |
የእሴቶች ተመላሽ | -15.69% | — |
የካፒታል ተመላሽ | -30.85% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (USD) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | -6.12 ሚ | -162.98% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | — | — |
ገንዘብ ከኢንቨስትመንት | — | — |
ገንዘብ ከፋይናንስ | — | — |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | — | — |
ነፃ የገንዘብ ፍሰት | — | — |
ስለ
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
10 ፌብ 1993
ድህረገፅ
ሠራተኞች
74
